NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Freya Biosciences

Freya Biosciences

Private
CopenhagenHealthcare & Life Scienceshttps://freyabiosciences.com/

Last Round

Series A

Extension

Nov 19, 2024

Total Funding Raised

$57.8M

Company Overview

Freya Biosciences is a biotechnology company developing microbial immunotherapies to address immune drivers of reproductive health conditions in women.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

microbial immunotherapyvaginal microbiomefemtechreproductive healthmicrobiome therapeuticsbacterial vaginosisIVF implantation failuremulti-omicsdrug discoveryclinical-stage biotechbiobankprecision medicinewomen's health biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Freya Biosciences Comparables

Compare Freya Biosciences with similar companies based on industry and business-model similarity.

Freya Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vaginal Biome Science
81%
Osel Inc.
78%
Gedea Biotech
72%

Freya Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 19, 2024
Series ADec 12, 2023

Key People

Founding team and executive leadership

Colleen Acosta

Co-Founder, CEO, Board Member

Founding Team

Freya Biosciences Investors

Notable investors and investment history

Freya Biosciences investors
InvestorRounds
OMX VenturesSeries A
Indaco Venture Partners SGRSeries A
Corundum Systems BiologySeries A
Bill & Melinda Gates FoundationSeries A Extension
The Bill & Melinda Gates Foundation TrustSeries A Extension
Angelini VenturesSeries A
The Export and Investment Fund of DenmarkSeries A Extension, Series A

Freya Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Freya Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Freya Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range27
Year Founded2020
Last FundingNov 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.